Register for email alerts and news feeds:
This journal | BMJ Group
rss
The most recent version of this article was published on 15 September 2009

Heart. Published Online First: 11 June 2009. doi:10.1136/hrt.2009.170696
Copyright © 2009 BMJ Publishing Group Ltd & British Cardiovascular Society

Original articles

Evaluation of novel biomarkers for the diagnosis of acute destabilized heart failure in shortness-of-breath patients

Benjamin Dieplinger 1, Alfons Gegenhuber 2, Meinhard Haltmayer 1 and Thomas Mueller 1*

1 Konventhospital Barmherzige Brueder Linz, Austria
2 Krankenhaus Bad Ischl, Austria

* To whom correspondence should be addressed. E-mail: thomas.mueller{at}bs-lab.at.

Accepted 26 May 2009


Abstract

Objective: The evaluation of novel biomarkers for the diagnosis of acute destabilized heart failure (HF).

Design: Prospectively conducted study on diagnostic accuracy.

Setting: Emergency department of a tertiary care hospital.

Patients: 251 consecutive patients presenting to the emergency department with dyspnoea as chief complaint.

Main outcome measures: Index tests were plasma concentrations of ten biomarkers (i.e., BNP, MR-proANP, MR-proADM, copeptin, CT-proET-1, ST2, adiponectin, chromogranin A, proguanylin, and prouroguanylin). The reference standard was the diagnosis of acute destabilized HF which was based on the Framingham score for HF plus echocardiographic evidence of systolic or diastolic dysfunction.

Results: Median plasma concentrations of all ten biomarkers were higher in patients with dyspnoea attributable to acute destabilized HF (n=137) than in patients with dyspnoea attributable to other reasons (n=114). Applying receiver operating characteristic curve (ROC) analyses, areas under the curve (AUCs) for BNP (0.92) and MR-proANP (0.88) were significantly higher than the AUCs of the other eight biomarkers (MR-proADM, 0.75; adiponectin, 0.73; CT-proET-1, 0.72; proguanylin, 0.68; ST2, 0.67; prouroguanylin, 0.62; copeptin, 0.62; and chromogranin A, 0.56). In multivariate logistic regression analysis only increased BNP and MR-proANP concentrations remained independent markers for the diagnosis of HF. Both makers alone or in combination added similar diagnostic information besides all clinical information available in the emergency department.

Conclusions: Our data showed that BNP and MR-proANP were the only independent diagnostic markers of HF. Both markers provided similar diagnostic information and were clinically useful as an aid in the diagnosis of acute destabilized HF in an emergency setting.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

eLetters:

Read all eLetters

MULTI MARKER OR SINGLE MARKER, CLINICAL CORRELATION IS A MUST
Dr.Srikanth .S Achanta
Online, 24 Jun 2009 [Full text]

This Article

Services
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.